SCHEMBL19397308

SCHEMBL19397308

Cc1cc(C)cc(-c2cc(-c3ccc(-c4ccccc4)cc3)nc(C)n2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.59
TP53 P04637 3/20 0.59
LMNA P02545 2/20 0.59
KMT2A Q03164 9/20 0.56
MEN1 O00255 8/20 0.56
ALDH1A1 P00352 4/20 0.56
L3MBTL1 Q9Y468 4/20 0.56
HPGD P15428 3/20 0.56
KDM4E B2RXH2 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
AGTR1 P30556 1/20 0.51
POLB P06746 2/20 0.51
PKM P14618 1/20 0.49
RAB9A P51151 1/20 0.49
TSHR P16473 2/20 0.47
ATM Q13315 1/20 0.47
ADORA2A P29274 2/20 0.47
ADORA1 P30542 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16353106 0.90 KMT2A (0.60) MAPTTP53LMNAKMT2AMEN1
SCHEMBL17286932 0.90 KMT2A (0.60) MAPTTP53LMNAKMT2AMEN1
SCHEMBL19397307 0.89 KMT2A (0.70) MAPTTP53LMNAKMT2AMEN1
SCHEMBL19397318 0.87 KMT2A (0.54) MAPTTP53LMNAKMT2AMEN1
SCHEMBL18900464 0.86 KMT2A (0.72) MAPTTP53LMNAKMT2AMEN1
SCHEMBL10039374 0.86 KMT2A (0.60) MAPTTP53LMNAKMT2AMEN1
SCHEMBL18267903 0.85 MEN1 (0.63) MAPTTP53LMNAKMT2AMEN1
SCHEMBL18562524 0.85 KMT2A (0.55) MAPTTP53LMNAKMT2AMEN1
SCHEMBL18267890 0.85 MEN1 (0.59) MAPTTP53LMNAKMT2AMEN1
SCHEMBL20251432 0.85 MEN1 (0.58) MAPTTP53LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 MAPT 3912/4885TP53 3837/4885LMNA 1449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.